Literature DB >> 10868826

Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.

H Yeni-Komshian1, M Carantoni, F Abbasi, G M Reaven.   

Abstract

OBJECTIVE: The goal of this study was to define the relationship between a quantitative measure of the ability of physiological hyperinsulinemia to stimulate glucose disposal and several surrogate measures of insulin resistance. RESEARCH DESIGN AND METHODS: Insulin-mediated glucose disposal was quantified in 490 healthy nondiabetic volunteers by determining the steady-state plasma glucose (SSPG) concentration in response to a continuous infusion of somatostatin, insulin, and glucose. Because the steady-state plasma insulin concentration was similar in all subjects during the infusion (approximately 60 microU/ml), the SSPG concentration provided a direct estimate of insulin-mediated glucose disposal. Relationships between this specific measure of insulin resistance and several surrogate estimates of insulin resistance based on plasma glucose and insulin concentrations were then defined.
RESULTS: The surrogate measure of insulin resistance most closely related to the direct determination of insulin action was the total integrated insulin response to a 75-g oral glucose challenge with correlation coefficients (r) varying from 0.67 to 0.79. Fasting plasma insulin concentration was significantly correlated (r = 0.61, P<0.001) to the specific estimate of insulin action. Two other surrogate estimates of insulin action, the ratio of fasting glucose-to-fasting insulin concentration and the homeostasis model assessment for insulin resistance, were no more closely related to SSPG than the fasting plasma insulin concentration.
CONCLUSIONS: The total integrated insulin response to oral glucose is the best surrogate measure of insulin resistance, accounting for approximately two-thirds of the variability in insulin-mediated glucose disposal. Fasting insulin concentration accounted for approximately one-third of the variability in insulin-mediated glucose disposal, and the use of fasting plasma glucose and insulin concentrations to calculate more sophisticated estimates of insulin resistance appears to offer little advantage over the fasting plasma insulin concentration. Given the large number of nondiabetic individuals in this study, the results should have general application in population-based studies, providing evidence for both the utility and limitation of the use of these surrogate measures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868826     DOI: 10.2337/diacare.23.2.171

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  88 in total

Review 1.  Diet and Syndrome X.

Authors:  G M Reaven
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

Review 2.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

3.  The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients.

Authors:  R Negro; G Formoso; H Hassan
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

4.  Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia.

Authors:  Sun H Kim; Teresa C Liu; Fahim Abbasi; Cindy Lamendola; John M Morton; Gerald M Reaven; Tracey L McLaughlin
Journal:  Obes Surg       Date:  2009-06-26       Impact factor: 4.129

5.  Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.

Authors:  Tomoko Asagami; Tyson H Holmes; Gerald Reaven
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

Review 6.  Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Authors:  Luciano Potena; Hannah A Valantine
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 7.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

8.  Relationship between surrogate estimates and direct measurement of insulin resistance in women with polycystic ovary syndrome.

Authors:  M H Dahan; F Abbasi; G Reaven
Journal:  J Endocrinol Invest       Date:  2019-01-30       Impact factor: 4.256

9.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

10.  Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women.

Authors:  T McLaughlin; A Deng; O Gonzales; M Aillaud; G Yee; C Lamendola; F Abbasi; A J Connolly; A Sherman; S W Cushman; G Reaven; P S Tsao
Journal:  Diabetologia       Date:  2008-09-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.